More on AKBA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.5 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Akebia Therapeutics (NQ:AKBA)
Delayed: 0.94 -0.01 (1.05%)
Prev. Close $0.95  
Open$0.95 
52 Wk High$13.20 
52 Wk Low$7.00 
Day High$0.95 
Day Low$0.93 
P/E N/A  
EPS$0.00 
Volume262,784 

Friends, Peers and Foes (?): QTTB (more...)

Sep 8, 2026 08:40 AM WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
Aug 10, 2026 04:09 PM Form 4 Akebia Therapeutics, For: Aug 06 Filed by: Butler John P.
Aug 7, 2026 06:11 AM Leerink Downgrades Akebia Therapeutics (AKBA) to Market Perform
Aug 6, 2026 06:58 AM H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)
Aug 5, 2026 05:10 PM Akebia Therapeutics (AKBA) Tops Q2 EPS by 1c
Aug 5, 2026 04:58 PM Form S-8 Akebia Therapeutics,
Aug 5, 2026 04:15 PM Form 10-Q Akebia Therapeutics, For: Jun 30
Aug 5, 2026 04:13 PM Form 8-K Akebia Therapeutics, For: Aug 05
Aug 5, 2026 04:06 PM Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 3, 2026 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with AKBA

View All Entities